ArticleCurrent medical science2026

Cadonilimab Plus Lenvatinib Combined with Stereotactic Body Radiotherapy for Conversion Therapy in Unresectable or Potentially Resectable Hepatocellular Carcinoma: A Study Protocol.

Jia-Jia Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.